2022
DOI: 10.3389/fbioe.2022.927461
|View full text |Cite
|
Sign up to set email alerts
|

Nano-Metal–Organic Framework Decorated With Pt Nanoparticles as an Efficient Theranostic Nanoprobe for CT/MRI/PAI Imaging-Guided Radio-Photothermal Synergistic Cancer Therapy

Abstract: The multifunctional theranostic nanoplatforms, which can realize changing the contrasts of medical images and enhance cancer therapies simultaneously, have attracted tremendous attention from chemists and medicine in past decades. Herein, a nanoscale metal–organic framework-based material was first synthesized and then decorated with platinum (NMOF545@Pt) successfully for multimodal imaging-guided synergistic cancer therapy. The obtained NMOF545@Pt is advantageous in shortening the longitudinal relaxation time… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 47 publications
(49 reference statements)
0
1
1
Order By: Relevance
“…2b. In a study by Ma et al, 69 the NMOF545@Pt synthesized from HfCl 4 , Mn-TCPP, and H 2 PtCl 6 exhibited a CT value of 110 HU, surpassing the MOF synthesized by Bao et al 64 The higher concentration of Pt (Z = 78) in this study may inuence signal enhancement in CT. Additionally, this study highlights NMOF545/Pt as a potential contrast agent for MRI/ CT/PAI imaging modalities, showcasing its promising role in diagnostic imaging technology. Similarly, You et al 63 fabricated a MOF-based therapeutic system integrating modalities such as CT, MRI, and FL for precise cancer chemotherapy.…”
Section: Computed Tomographycontrasting
confidence: 52%
“…2b. In a study by Ma et al, 69 the NMOF545@Pt synthesized from HfCl 4 , Mn-TCPP, and H 2 PtCl 6 exhibited a CT value of 110 HU, surpassing the MOF synthesized by Bao et al 64 The higher concentration of Pt (Z = 78) in this study may inuence signal enhancement in CT. Additionally, this study highlights NMOF545/Pt as a potential contrast agent for MRI/ CT/PAI imaging modalities, showcasing its promising role in diagnostic imaging technology. Similarly, You et al 63 fabricated a MOF-based therapeutic system integrating modalities such as CT, MRI, and FL for precise cancer chemotherapy.…”
Section: Computed Tomographycontrasting
confidence: 52%
“…Currently, most MRI nanoplatforms use chelating agents that can reduce both T 1 and T 2 relaxation times, such as Fe 3 O 4 or Gd 3+ . In addition, combining the CT imaging ability of Pt element, such as the Pt-modified nanomaterial NMOF545@Pt 88 synthesized by Ma et al In this composite material, the manganese( iii ) porphyrin is beneficial for shortening the longitudinal relaxation time, which can obtain T 1 -weighted MRI images, while the high atomic cluster effect of Pt can weaken X-ray penetration and enhance the quality of CT images. Furthermore, the platinum-based nanomedicine platform can also enhance the photoacoustic effects (Fig.…”
Section: Platinum Based Nanoplatforms For Application In Medical Mult...mentioning
confidence: 99%